Synthetic Biologics to Host Multiple Sclerosis-Estriol Investor Day in New York City on June 25, 2013 ROCKVILLE, Md., June 13, 2013 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of biologics focused on the prevention and treatment of serious infectious diseases, announced today that it will host a Multiple Sclerosis-Estriol Investor Day on Tuesday, June 25,...
June 13, 2013 - PR Newswire